Skip to content

Clinical trials

Phase 3 Endometrial Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 3 Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20022
20041
20051
20062
20073
20081
20092
20112
20122
20131
20152
20162
20171
20183
20195
20202
20216
20225
20234
20247
20256
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Recruiting16
Active, not recruiting13
Unknown status7
Terminated5
Not yet recruiting4
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC6
AstraZeneca4
European Organisation for Research and Treatment of Cancer - EORTC4
Gynecologic Oncology Group4
National Cancer Institute (NCI)3
Alliance for Clinical Trials in Oncology2
GlaxoSmithKline2
Karyopharm Therapeutics Inc2
Leiden University2
Leiden University Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms78
Uterine Cervical Neoplasms14
Ovarian Neoplasms12
Neoplasms10
Breast Neoplasms6
Fallopian Tube Neoplasms6
Sarcoma6
Uterine Neoplasms5
Vaginal Neoplasms5
Carcinoma, Ovarian Epithelial4

Trials

Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.